We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics
Read MoreHide Full Article
Tenet Healthcare (THC - Free Report) reported $5.38 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 7.8%. EPS of $2.68 for the same period compares to $1.96 a year ago.
The reported revenue represents a surprise of +2.18% over the Zacks Consensus Estimate of $5.26 billion. With the consensus EPS estimate being $1.58, the EPS surprise was +69.62%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Tenet performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Adjusted admissions: 250.34 thousand versus the two-analyst average estimate of 252.17 thousand.
Net patient revenue per adjusted patient admission: $15,055 compared to the $14,561 average estimate based on two analysts.
Net operating revenues- Hospital Operations and other: $4.30 billion versus $4.01 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +12% change.
Net operating revenues- Ambulatory Care: $1.08 billion compared to the $1.04 billion average estimate based on four analysts. The reported number represents a change of +15.4% year over year.
Net operating revenues: $5.38 billion versus the two-analyst average estimate of $5.22 billion. The reported number represents a year-over-year change of +7.8%.
Adjusted EBITDA- Hospital Operations and other: $548 million compared to the $380.03 million average estimate based on three analysts.
Adjusted EBITDA- Ambulatory Care: $464 million versus the three-analyst average estimate of $444.34 million.
Equity in earnings of unconsolidated affiliates: $73 million versus $59 million estimated by two analysts on average.
Shares of Tenet have returned +10.2% over the past month versus the Zacks S&P 500 composite's +6.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics
Tenet Healthcare (THC - Free Report) reported $5.38 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 7.8%. EPS of $2.68 for the same period compares to $1.96 a year ago.
The reported revenue represents a surprise of +2.18% over the Zacks Consensus Estimate of $5.26 billion. With the consensus EPS estimate being $1.58, the EPS surprise was +69.62%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Tenet performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Adjusted admissions: 250.34 thousand versus the two-analyst average estimate of 252.17 thousand.
- Net patient revenue per adjusted patient admission: $15,055 compared to the $14,561 average estimate based on two analysts.
- Net operating revenues- Hospital Operations and other: $4.30 billion versus $4.01 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +12% change.
- Net operating revenues- Ambulatory Care: $1.08 billion compared to the $1.04 billion average estimate based on four analysts. The reported number represents a change of +15.4% year over year.
- Net operating revenues: $5.38 billion versus the two-analyst average estimate of $5.22 billion. The reported number represents a year-over-year change of +7.8%.
- Adjusted EBITDA- Hospital Operations and other: $548 million compared to the $380.03 million average estimate based on three analysts.
- Adjusted EBITDA- Ambulatory Care: $464 million versus the three-analyst average estimate of $444.34 million.
- Equity in earnings of unconsolidated affiliates: $73 million versus $59 million estimated by two analysts on average.
View all Key Company Metrics for Tenet here>>>Shares of Tenet have returned +10.2% over the past month versus the Zacks S&P 500 composite's +6.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.